Cardiovascular implantable electrophysiological device-related infections: A review

Current Opinion in Cardiology

Volumn 26, Issue 1, 2011, Pages 6-11

  Gould, Paul A ^a   Gula, Lorne J ^a   Yee, Raymond ^a   Skanes, Allan C ^a   Klein, George J ^a   Krahn, Andrew D ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Device; Implantable cardioverter defibrillator; Infection; Pacemaker; Prosthesis related infections; Wound

Indexed keywords

CEFALEXIN;

ARTICLE; CARDIAC IMPLANTABLE ELECTROPHYSIOLOGICAL DEVICE; CLINICAL ASSESSMENT; HEART ASSIST DEVICE; HEART DISEASE; HEART TAMPONADE; HEMATOTHORAX; LUNG EMBOLISM; PNEUMONIA; PRIORITY JOURNAL;

CANDIDIASIS; CORYNEBACTERIUM INFECTIONS; DEFIBRILLATORS, IMPLANTABLE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; PROPIONIBACTERIUM ACNES; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 79951677021     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328341384e     Document Type: Article

References (43)

1. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006; 48:590-591. (Pubitemid 44093958)
2. Lin G, Meverden RA, Hodge DO, et al. Age and gender trends in implantable cardioverter defibrillator utilization: a population based study. J Interv Card Electrophysiol 2008; 22:65-70.
3. Uslan DZ, Tleyjeh IM, Baddour LM, et al. Temporal trends in permanent pacemaker implantation: a population-based study. Am Heart J 2008; 155:896-903.
4. Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 2007; 167:669-675. (Pubitemid 46598459)
5. Conklin EF, Giannelli S Jr, Nealon TF Jr. Four hundred consecutive patients with permanent transvenous pacemakers. J Thorac Cardiovasc Surg 1975; 69:1-7.
6. Bluhm G. Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins. Acta Med Scand Suppl 1985; 699:1-62.
7. Duval X, Selton-Suty C, Alla F, et al. Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis 2004; 39:68-74. (Pubitemid 38879551)
8. Mela T, McGovern BA, Garan H, et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants. Am J Cardiol 2001; 88:750-753.
9. Cabell CH, Heidenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 2004; 147:582-586. (Pubitemid 38900441)
10. Klug D, Balde M, Pavin D, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007; 116:1349-1355. (Pubitemid 47417560)
11. Bloom H, Heeke B, Leon A, et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006; 29:142-145.
12. Lekkerkerker JC, van Nieuwkoop C, Trines SA, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 2009; 95:715-720.
13. Sohail MR, Uslan DZ, Khan AH, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007; 45:166-173. (Pubitemid 47041006)
14. Gould PA, Krahn AD. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA 2006; 295:1907-1911.
15. Gould PA, Gula LJ, Champagne J, et al. Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up. Heart Rhythm 2008; 5:1675-1681.
16. Al Khatib SM, Lucas FL, Jollis JG, et al. The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol 2005; 46:1536-1540. (Pubitemid 41446191)
17. Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis 2001; 33:1567-1572. (Pubitemid 34246153)
18. Pfaller MA, Herwaldt LA. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1988; 1:281-299.
19. Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007; 49:1851-1859. (Pubitemid 46661104)
20. Villamil CI, Rodriguez FM, Van den Eynde CA, et al. Permanent transvenous pacemaker infections: an analysis of 59 cases. Eur J Intern Med 2007; 18:484-488.
21. Kloos WE, Bannerman TL. Update on clinical significance of coagulasenegative staphylococci. Clin Microbiol Rev 1994; 7:117-140. (Pubitemid 24038092)
22. Bertaglia E, Zerbo F, Zardo S, et al. Antibiotic prophylaxis with a single dose of cefazolin during pacemaker implantation: incidence of long-term infective complications. Pacing Clin Electrophysiol 2006; 29:29-33.
23. Chua JD, Wilkoff BL, Lee I, et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133:604-608.
24. Da Costa A, Lelievre H, Kirkorian G, et al. Role of the preaxillary flora in pacemaker infections: a prospective study. Circulation 1998; 97:1791-1795. (Pubitemid 28213622)
25. Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 1997; 95:2098-2107. (Pubitemid 27184278)
26. Voet JG, Vandekerckhove YR, Muyldermans LL, et al. Pacemaker lead infection: report of three cases and review of the literature. Heart 1999; 81:88-91. (Pubitemid 29113210)
27. Dekker RJ, van Soest S, Fontijn RD, et al. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood 2002; 100:1689-1698. (Pubitemid 34925146)
28. Fowler VG Jr, Li J, Corey GR, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997; 30:1072-1078. (Pubitemid 27435904)
29. Howarth DM, Curteis PG, Gibson S. Infected cardiac pacemaker wires demonstrated by Tc-99m labeled white blood cell scintigraphy. Clin Nucl Med 1998; 23:74-76. (Pubitemid 28104046)
30. Wickline SA, Fischer KC. Can infections be imaged in implanted devices? ASAIO J 2000; 46:S80-S81.
31. Dy CJ, Abdul-Karim A, Mawhorter S, et al. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pacing Clin Electrophysiol 2005; 28:1276-1281. (Pubitemid 43951387)
32. Mason PK, DiMarco JP, Ferguson JD, et al. Sonication of explanted cardiac rhythm management devices for the diagnosis of pocket infections and asymptomatic bacterial colonization. Pacing Clin Electrophysiol 2010. [Epub ahead of print]
33. Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular device-related infections. Circulation 2003; 108:2015-2031. (Pubitemid 37296549)
34. Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010; 121:458-477.
35. Jones SO, Eckart RE, Albert CM, et al. Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications. Heart Rhythm 2008; 5:520-525.
36. Ghosh N, Yee R, Klein GJ, et al. Laser lead extraction: is there a learning curve? Pacing Clin Electrophysiol 2005; 28:180-184. (Pubitemid 40393103)
37. Field ME, Jones SO, Epstein LM. How to select patients for lead extraction. Heart Rhythm 2007; 4:978-985. (Pubitemid 46959211)
38. Uslan DZ, Dowsley TF, Sohail MR, et al. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol 2010; 33:407-413.
39. Uslan DZ, Sohail MR, Friedman PA, et al. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis 2006; 43:731-736. (Pubitemid 44330736)
40. Baddour LM. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci 2001; 322:209-212. (Pubitemid 32973273)
41. Braun MU, Rauwolf T, Bock M, et al. Percutaneous lead implantation connected to an external device in stimulation-dependent patients with systemic infection: a prospective and controlled study. Pacing Clin Electrophysiol 2006; 29:875-879. (Pubitemid 44222141)
42. Nandyala R, Parsonnet V. One stage side-to-side replacement of infected pulse generators and leads. Pacing Clin Electrophysiol 2006; 29:393-396.
43. Panja M, Sarkar CN, Kumar S, et al. Reuse of pacemaker. Indian Heart J 1996; 48:677-680. (Pubitemid 127540881)